Regulatory Update
🌍 AU/AMA Level
Dr. Delese Mimi Darko Appointed Inaugural Director General of the African Medicines Agency
A
African Union Press Office
African Union Commission
The Conference of State Parties (CoSP) of the African Medicines Agency (AMA) announced the appointment of Dr. Delese Mimi Darko from the Republic of Ghana as the inaugural Director General of the African Medicines Agency. The nomination took place during the 2nd Ordinary Session of the CoSP, held from 2-4 June 2025 in Kigali, Rwanda.
Dr. Darko, renowned for her exemplary leadership as the Chief Executive Officer of the Ghana Food and Drugs Authority (FDA), brings a wealth of experience and a distinguished track record in regulatory excellence to her new role. Her appointment signifies a bold step forward in strengthening regulatory oversight, promoting access to quality, safe, and efficacious medicines, and fostering pharmaceutical innovation across Africa.
Significance of the Appointment:
"The appointment of the Director General is an important step toward the operationalisation of AMA," stated H.E. Amb. Amma Twum-Amoah, Commissioner for Health, Humanitarian Affairs and Social Development of the African Union. "The AMA has been established to harmonize and strengthen regulatory systems for medical products across Africa."
Dr. Francine Dekandji, Minister of State of Health, Chad and Chairperson of the AMA Conference of State Parties, congratulated Dr. Darko: "The AMA, as a specialized agency of the African Union, is crucial for ensuring that medical products on our continent meet international standards of quality, safety, and efficacy."
AMA Governance Structure:
During the three-day meeting, the Conference of State Parties elected a new Bureau and endorsed an additional member to the AMA Governing Board. The Governing Board is responsible for providing strategic direction, technical decision making, guidance, and monitoring the performance of the Agency.
About the African Medicines Agency:
The AMA is a specialized agency of the African Union established to harmonize and strengthen regulatory systems for medical products across Africa. Headquartered in Kigali, Rwanda, the AMA works to ensure access to quality, safe, and efficacious medical products across all 55 African Union member states.
The agency's establishment is a cornerstone of the African Union's Agenda 2063, aiming to build a prosperous and healthy Africa. The AMA builds on the success of the African Medicines Regulatory Harmonization (AMRH) program and represents a major milestone in African Union health initiatives.
Dr. Darko, renowned for her exemplary leadership as the Chief Executive Officer of the Ghana Food and Drugs Authority (FDA), brings a wealth of experience and a distinguished track record in regulatory excellence to her new role. Her appointment signifies a bold step forward in strengthening regulatory oversight, promoting access to quality, safe, and efficacious medicines, and fostering pharmaceutical innovation across Africa.
Significance of the Appointment:
"The appointment of the Director General is an important step toward the operationalisation of AMA," stated H.E. Amb. Amma Twum-Amoah, Commissioner for Health, Humanitarian Affairs and Social Development of the African Union. "The AMA has been established to harmonize and strengthen regulatory systems for medical products across Africa."
Dr. Francine Dekandji, Minister of State of Health, Chad and Chairperson of the AMA Conference of State Parties, congratulated Dr. Darko: "The AMA, as a specialized agency of the African Union, is crucial for ensuring that medical products on our continent meet international standards of quality, safety, and efficacy."
AMA Governance Structure:
During the three-day meeting, the Conference of State Parties elected a new Bureau and endorsed an additional member to the AMA Governing Board. The Governing Board is responsible for providing strategic direction, technical decision making, guidance, and monitoring the performance of the Agency.
About the African Medicines Agency:
The AMA is a specialized agency of the African Union established to harmonize and strengthen regulatory systems for medical products across Africa. Headquartered in Kigali, Rwanda, the AMA works to ensure access to quality, safe, and efficacious medical products across all 55 African Union member states.
The agency's establishment is a cornerstone of the African Union's Agenda 2063, aiming to build a prosperous and healthy Africa. The AMA builds on the success of the African Medicines Regulatory Harmonization (AMRH) program and represents a major milestone in African Union health initiatives.
Tags:
ama
african medicines agency
dr delese mimi darko
ghana
director general
african union
kigali
Published: June 04, 2025
Views: 43